首页> 美国卫生研究院文献>Acta Neuropathologica Communications >Preserving prion strain identity upon replication of prions in vitro using recombinant prion protein
【2h】

Preserving prion strain identity upon replication of prions in vitro using recombinant prion protein

机译:使用重组病毒蛋白在体外复制replication病毒时保留病毒菌株同一性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Last decade witnessed an enormous progress in generating authentic infectious prions or PrPSc in vitro using recombinant prion protein (rPrP). Previous work established that rPrP that lacks posttranslational modification is able to support replication of highly infectious PrPSc with assistance of cofactors of polyanionic nature and/or lipids. Unexpectedly, previous studies also revealed that seeding of rPrP by brain-derived PrPSc gave rise to new prion strains with new disease phenotypes documenting loss of a strain identity upon replication in rPrP substrate. Up to now, it remains unclear whether prion strain identity can be preserved upon replication in rPrP. The current study reports that faithful replication of hamster strain SSLOW could be achieved in vitro using rPrP as a substrate. We found that a mixture of phosphatidylethanolamine (PE) and synthetic nucleic acid polyA was sufficient for stable replication of hamster brain-derived SSLOW PrPSc in serial Protein Misfolding Cyclic Amplification (sPMCA) that uses hamster rPrP as a substrate. The disease phenotype generated in hamsters upon transmission of recombinant PrPSc produced in vitro was strikingly similar to the original SSLOW diseases phenotype with respect to the incubation time to disease, as well as clinical, neuropathological and biochemical features. Infrared microspectroscopy (IR-MSP) indicated that PrPSc produced in animals upon transmission of recombinant PrPSc is structurally similar if not identical to the original SSLOW PrPSc. The current study is the first to demonstrate that rPrP can support replication of brain-derived PrPSc while preserving its strain identity. In addition, the current work is the first to document that successful propagation of a hamster strain could be achieved in vitro using hamster rPrP.Electronic supplementary materialThe online version of this article (10.1186/s40478-018-0597-y) contains supplementary material, which is available to authorized users.
机译:过去十年见证了使用重组病毒蛋白(rPrP)在体外产生真正的感染性ions病毒或PrP Sc 的巨大进步。先前的工作表明,缺少翻译后修饰的rPrP能够在聚阴离子性质和/或脂质的辅助因子的辅助下支持高感染性PrP Sc 的复制。出乎意料的是,先前的研究还表明,脑源性PrP Sc 播种rPrP产生了具有新疾病表型的新病毒菌株,该表型表明在rPrP底物中复制后丧失了菌株同一性。迄今为止,仍不清楚在rPrP中复制后能否保留病毒菌株的身份。目前的研究报道,使用rPrP作为底物,可以在体外实现仓鼠品系SSLOW的忠实复制。我们发现,磷脂酰乙醇胺(PE)和合成核酸polyA的混合物足以在仓鼠rPrP作为仓鼠的连续蛋白错折叠循环扩增(sPMCA)中稳定复制仓鼠脑来源的SSLOW PrP Sc 。基质。就疾病的潜伏时间以及临床,神经病理和生化特征而言,通过体外产生的重组PrP Sc 的传播,仓鼠中产生的疾病表型与原始SSLOW疾病表型极为相似。红外光谱(IR-MSP)表明,重组PrP Sc 传播后在动物体内产生的PrP Sc 在结构上与原始的SSLOW PrP Sc <不相同。 / sup>。目前的研究是第一个证明rPrP可以支持脑源性PrP Sc 的复制并同时保留其菌株同一性的研究。此外,当前的工作是第一个文献证明使用仓鼠rPrP可以在体外成功繁殖仓鼠菌株。电子补充材料本文的在线版本(10.1186 / s40478-018-0597-y)包含补充材料,可供授权用户使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号